Ligand Pharmaceuticals (LGND)
Healthcare · Biotechnology
1 member of Congress has disclosed 4 trades in Ligand Pharmaceuticals (LGND) since 2026: 4 buys and 0 sales. The most recent was disclosed on Jun 8, 2026.
- Trades disclosed
- 4
- Members trading
- 1
- Buys / sells
- 4 / 0
- Reported value
- $4K–$60K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at LGND
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded LGND
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)4 buys · 0 sales40Jun 8, 2026
All trades
- Jun 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 7, 2026
- Feb 13, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded Jan 15, 2026 · disclosed Feb 13, 2026
- Feb 13, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded Jan 5, 2026 · disclosed Feb 13, 2026
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.